Patricia Drake
Corporate Officer/Principal bei TREVENA, INC.
Vermögen: 41 760 $ am 31.05.2024
Aktive Positionen von Patricia Drake
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TREVENA, INC. | Corporate Officer/Principal | 11.11.2021 | - |
Karriereverlauf von Patricia Drake
Ehemalige bekannte Positionen von Patricia Drake
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.06.2021 | 01.09.2021 |
| MSD Finland Oy | Vorstandsvorsitzender | 01.01.2019 | 01.05.2021 |
Ausbildung von Patricia Drake
| Wichita State University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Finnland | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TREVENA, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
| MSD Finland Oy |
- Börse
- Insiders
- Patricia Drake
- Erfahrung
